Beijing, China

Xiangrong Cao

This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Beijing Tide Pharmaceutical Co., Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xiangrong Cao. Retrieved from https://idiyas.com/inventor/xiangrong-cao

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

% Patents Active = 50.0

 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Xiangrong Cao and His Pharmaceutical Patent

Introduction

Xiangrong Cao is an inventor based in Beijing, China, associated with Beijing Tide Pharmaceutical Co., Ltd. His patent work concerns a pharmaceutical compound developed as a Rho-associated protein kinase (ROCK) inhibitor.

Latest Patents

The provided information lists one patent associated with Cao: “Salt of Rho-associated protein kinase inhibitor, solid form of the salt, preparation method for same, and uses thereof.” The invention covers a salt of compound A, a solid form of that salt, methods for preparing the solid form, pharmaceutical compositions containing it, and its use as a ROCK inhibitor, preferably a selective ROCK2 inhibitor. The record lists 1 patent for Cao.

Career Highlights

Cao’s listed patent reflects work on the development and preparation of a pharmaceutical solid form, as well as its potential therapeutic application. He is associated with Beijing Tide Pharmaceutical Co., Ltd.

Collaborations

Hongjun Wang and Zewang Feng are identified as Cao’s coworkers in the provided information.

Conclusion

Xiangrong Cao’s listed invention focuses on a ROCK inhibitor salt and its solid form, preparation, and pharmaceutical uses, highlighting his connection to pharmaceutical research at Beijing Tide Pharmaceutical Co., Ltd.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…